BackFusion Pharmaceuticals Overview

Fusion Pharmaceuticals Receivables

Track Fusion Pharmaceuticals's receivables ($4.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$4.68M
↑ 84.18% YoYΔ $2.14M vs prior year quarter

Peer trimmed avg / median

Loading

Fusion Pharmaceuticals Receivables History

Loading

Fusion Pharmaceuticals vs. peers: Receivables Comparison

Loading

Fusion Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fusion Pharmaceuticals (FUSN) FAQ

Fusion Pharmaceuticals (FUSN) currently reports a receivables of $4.7M as of March 2024. That compares with $2.5M in the prior-year period — up 84.2% year over year. Use the charts on this page to explore Fusion Pharmaceuticals's receivables history and peer comparisons.

Fusion Pharmaceuticals's receivables increased from $2.5M to $4.7M — a 84.2% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fusion Pharmaceuticals reported $4.7M in receivables as of March 2024. That compares with $2.5M in the prior-year period — up 84.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $4.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fusion Pharmaceuticals, and consider following FUSN for alerts when major investors trade the stock.

Fusion Pharmaceuticals is classified in the Healthcare sector. On receivables, it currently shows $4.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FUSN with unrelated industries.